Patent · US Active

Heterocyclic compound

US11814371B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Guanglong SUN · Shanghai, CN
Chunli Shen · Shanghai, CN
Chengde Wu · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Mar 4, 2021
Grant date	Nov 14, 2023
Priority date	—
Expiry date	May 8, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present application relates to the field of medicine. Specifically, disclosed are a compound of formula (I), a preparation method therefor, and a pharmaceutical composition comprising the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.